We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00363272
First Posted: August 15, 2006
Last Update Posted: January 16, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
National Cancer Institute (NCI)
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: No date given
  Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)